These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 31804030

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical characteristics and prognosis of patients with myelodysplastic syndrome with a bone marrow nucleated erythroid cell proportion of greater than or equal to 50].
    Zeng YP, Li B, Qin TJ, Xu ZF, Qu SJ, Pan LJ, Gao QY, Jiao M, Wu JY, Wang HJ, Li CW, Ja YJ, Sun Q, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jul 14; 45(7):651-659. PubMed ID: 39231769
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Mutations and prognosis in myelodysplastic syndromes: karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model.
    Gangat N, Mudireddy M, Lasho TL, Finke CM, Nicolosi M, Szuber N, Patnaik MM, Pardanani A, Hanson CA, Ketterling RP, Tefferi A.
    Am J Hematol; 2018 May 14; 93(5):691-697. PubMed ID: 29417633
    [Abstract] [Full Text] [Related]

  • 25. The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm.
    Ibrar W, Zhang W, Cox JL, Cushman-Vokoun A, Fu K, Greiner TC, Yuan J.
    Int J Lab Hematol; 2021 Dec 14; 43(6):1501-1509. PubMed ID: 34270867
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Characteristics and Clinical Significance of Gene Mutation in Patients with Myelodysplastic Syndrome].
    Zhao F, Wang KL, Qin YT, Nilupar T, Patiguli A, Jiang M, Hao JP.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec 14; 29(6):1864-1868. PubMed ID: 34893124
    [Abstract] [Full Text] [Related]

  • 28. [Clinical Characteristics and Prognosis of Myelodysplastic Syndromes Patients with RUNX1 Gene Mutation].
    Chen Y, Ji YR, Zhang JY, Qin WW, Liu CC, Liu L, Yan XQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug 14; 32(4):1173-1180. PubMed ID: 39192415
    [Abstract] [Full Text] [Related]

  • 29. Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS.
    Nazha A, Bejar R.
    Curr Hematol Malig Rep; 2017 Oct 14; 12(5):461-467. PubMed ID: 28844082
    [Abstract] [Full Text] [Related]

  • 30. Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.
    Yang L, Wei X, Gong Y.
    Cancer Med; 2024 Jan 14; 13(1):e6871. PubMed ID: 38146893
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Analysis of mutations of 14 genes among 87 patients with myelodysplastic syndrome].
    Zhou X, Jin H, Mu Q, Sheng L, Lai B, Zhu H, Ouyang G.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct 10; 36(10):953-956. PubMed ID: 31598934
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation.
    Wu X, Deng J, Zhang N, Liu X, Zheng X, Yan T, Ye W, Gong Y.
    BMC Cancer; 2022 Mar 12; 22(1):262. PubMed ID: 35279121
    [Abstract] [Full Text] [Related]

  • 37. Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts.
    Chen Z, Wang SA, Goswami M, Tang G, Routbort MJ, Patel KP, Luthra R, Medeiros LJ, Ok CY.
    Leuk Res; 2019 Nov 12; 86():106227. PubMed ID: 31557598
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prognostic value of SRSF2 mutations in patients with de novo myelodysplastic syndromes: A meta-analysis.
    Zheng X, Zhan Z, Naren D, Li J, Yan T, Gong Y.
    PLoS One; 2017 Nov 12; 12(9):e0185053. PubMed ID: 28953917
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.